Healthcare - Biotechnology - NASDAQ - US
$ 5.84
-5.96 %
$ 222 M
Market Cap
-3.74
P/E
BALANCE SHEET
95.2 M
ASSETS
27.2 M
LIABILITIES
68 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Orchestra BioMed Holdings, Inc.
| Current Assets | 89.1 M |
| Cash & Short-Term Investments | 87.6 M |
| Receivables | 99 K |
| Other Current Assets | 1.42 M |
| Non-Current Assets | 6.1 M |
| Long-Term Investments | 2.5 M |
| PP&E | 2.83 M |
| Other Non-Current Assets | 769 K |
| Current Liabilities | 11.2 M |
| Accounts Payable | 2.9 M |
| Short-Term Debt | 1.3 M |
| Other Current Liabilities | 7.01 M |
| Non-Current Liabilities | 16 M |
| Long-Term Debt | 1.04 M |
| Other Non-Current Liabilities | 14.9 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| ASSETS | ||||
| Cash & Cash Equivalents | 30.6 | 19.8 | 9.9 | 20.3 |
| Short Term Investments | 57.0 | 64.0 | 1.0 | 15.4 |
| Receivables | 99 K | 96 K | 0.1 | 0.2 |
| Inventory | 0.1 | 0.3 | 68 K | 69 K |
| Other Current Assets | 1.3 | 0.5 | 0.2 | 0.2 |
| Total Current Assets | 89.1 | 84.7 | 11.3 | 36.3 |
| PP&E | 2.8 | 3.7 | 1.1 | 1.0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 |
| Long Term Investments | 2.5 | 2.5 | 0.4 | 0.2 |
| Other Long Term Assets | 0.8 | 4.7 | 0.7 | 0.6 |
| Other Assets | 0 | 0 | 0 | 0 |
| Total Assets | 95.2 | 95.6 | 13.5 | 38.1 |
| LIABILITIES | ||||
| Accounts Payable | 2.9 | 4.0 | 2.0 | 1.8 |
| Short Term Debt | 1.3 | 0.7 | 2.0 | 4.0 |
| Other Current Liabilities | 4.5 | 7.5 | 8.2 | 8.5 |
| Total Current Liabilities | 11.2 | 18.6 | 12.2 | 14.4 |
| Long Term Debt | 1.0 | 11.2 | 3.7 | 5.5 |
| Deferred Tax Income | 0 | 1.7 | 51.5 | 51.5 |
| Other Liabilities | 0 | 0.2 | (34.1) | (36.1) |
| Total Liabilities | 27.2 | 43.0 | 84.8 | 86.6 |
| EQUITY | ||||
| Common Stock | 4 K | 2 K | 160.0 | 160.0 |
| Retained Earnings | (248.9) | (199.7) | (166.1) | (143.1) |
| Other Accumulative Comprehensive Income/Loss | 10 K | 8 K | (211.5) | 2 K |
| Total Equity | 68.0 | 52.5 | (71.2) | (48.5) |
| Total Liabilities and Equity | 95.2 | 95.6 | 13.5 | 38.1 |
| SHARES OUTSTANDING | ||||
| Common Shares Outstanding | 33.2 | 15.0 | 20.4 | 20.4 |